Methods and compositions for risk prediction, diagnosis, prognosis, and treatment of pulmonary disorders
US11649503B2 · kind B2 · utility
1Cited by
3References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 6, 2020 |
| Grant date | May 16, 2023 |
| Priority date | — |
| Expiry date | Nov 10, 2040 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/12
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention provides diagnostic and therapeutic targets for pulmonary disease, in particular, fibrotic lung disease. The inventors have found that a genetic variant MUC5B gene is associated with increased expression of the gene, increased risk of developing a pulmonary disease, and an improved prognosis and survival among those developing the pulmonary disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.